Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
University of Iowa
mi
from
Iowa City, IA
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Massachusetts General Hospital
mi
from
Boston, MA
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Henry Ford Health Systems
mi
from
Detroit, MI
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Henry Ford Health Systems
mi
from
Detroit, MI
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
St. Louis University
mi
from
St Louis, MO
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
St. Louis University
mi
from
St Louis, MO
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Neurology Associates PC
mi
from
Lincoln, NE
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Neurology Associates PC
mi
from
Lincoln, NE
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Hospital for Special Surgery
mi
from
New York, NY
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Carolinas Health Care
mi
from
Charlotte, NC
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Carolinas Health Care
mi
from
Charlotte, NC
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Wake Forest University
mi
from
Winston-Salem, NC
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Cleveland Clinic
mi
from
Cleveland, OH
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Ohio State University
mi
from
Columbus, OH
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Providence ALS Center
mi
from
Portland, OR
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Providence ALS Center
mi
from
Portland, OR
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Drexel University
mi
from
Philadelphia, PA
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
University of Texas
mi
from
San Antonio, TX
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
University of Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
University of Vermont
mi
from
Burlington, VT
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  12/22/2016
University of Texas Southwestern
mi
from
Dallas, TX
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 12/22/2016
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
Phase I Single Dose, Open-label, Pharmacokinetic Study Followed by Single-blind, Placebo-controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Plasma Concentration Profiles, and Targeted Efficacy of NFC-1 in Adolescents (12-17 Years of Age) With Attention-Deficit Hyperactivity Disorder and Genetic Disruption Impacting Metabotropic Glutamate Receptor Genes (NFC1-GREAT)
Status: Enrolling
Updated:  12/22/2016
Thomas Jefferson University, Clinical Research Unit
mi
from
Philadelphia, PA
Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
Phase I Single Dose, Open-label, Pharmacokinetic Study Followed by Single-blind, Placebo-controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Plasma Concentration Profiles, and Targeted Efficacy of NFC-1 in Adolescents (12-17 Years of Age) With Attention-Deficit Hyperactivity Disorder and Genetic Disruption Impacting Metabotropic Glutamate Receptor Genes (NFC1-GREAT)
Status: Enrolling
Updated: 12/22/2016
Thomas Jefferson University, Clinical Research Unit
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  12/27/2016
University of Michigan
mi
from
Ann Arbor, MI
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 12/27/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  12/27/2016
St. Joseph Mercy Canton
mi
from
Canton, MI
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 12/27/2016
St. Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  12/27/2016
St. Joseph Mercy Chelsea
mi
from
Chelsea, MI
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 12/27/2016
St. Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  12/27/2016
St. Joseph Mercy Livingston
mi
from
Howell, MI
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 12/27/2016
St. Joseph Mercy Livingston
mi
from
Howell, MI
Click here to add this to my saved trials
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  12/27/2016
St. Joseph Mercy Ann Arbor
mi
from
Ypsilanti, MI
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 12/27/2016
St. Joseph Mercy Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy
A Pilot Study of a Strength and Balance Training Program for Persons With Oxaliplatin Induced Peripheral Neuropathy
Status: Enrolling
Updated:  12/28/2016
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy
A Pilot Study of a Strength and Balance Training Program for Persons With Oxaliplatin Induced Peripheral Neuropathy
Status: Enrolling
Updated: 12/28/2016
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Alternative Treatment Paradigm for Natalizumab Trial
Alternative Treatment Paradigm for Natalizumab Trial
Status: Enrolling
Updated:  12/28/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Alternative Treatment Paradigm for Natalizumab Trial
Alternative Treatment Paradigm for Natalizumab Trial
Status: Enrolling
Updated: 12/28/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD)
Development of a Multi-faceted Cognitive Training Program for Children With ADHD
Status: Enrolling
Updated:  12/29/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD)
Development of a Multi-faceted Cognitive Training Program for Children With ADHD
Status: Enrolling
Updated: 12/29/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
Status: Enrolling
Updated:  12/29/2016
Clinical Research Facility
mi
from
Baltimore, MD
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
Status: Enrolling
Updated: 12/29/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
Status: Enrolling
Updated:  12/29/2016
Clinical Research Facility
mi
from
Glendale, CA
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
Status: Enrolling
Updated: 12/29/2016
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology (4 Hour Use)
Status: Enrolling
Updated:  12/29/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology (4 Hour Use)
Status: Enrolling
Updated: 12/29/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Mental Practice in Chronic, Stroke Induced Hemiparesis
Mental Practice in Chronic, Stroke-Induced Hemiparesis
Status: Enrolling
Updated:  1/4/2017
Metrohealth
mi
from
Cleveland, OH
Mental Practice in Chronic, Stroke Induced Hemiparesis
Mental Practice in Chronic, Stroke-Induced Hemiparesis
Status: Enrolling
Updated: 1/4/2017
Metrohealth
mi
from
Cleveland, OH
Click here to add this to my saved trials
Mental Practice in Chronic, Stroke Induced Hemiparesis
Mental Practice in Chronic, Stroke-Induced Hemiparesis
Status: Enrolling
Updated:  1/4/2017
Ohio State University
mi
from
Columbus, OH
Mental Practice in Chronic, Stroke Induced Hemiparesis
Mental Practice in Chronic, Stroke-Induced Hemiparesis
Status: Enrolling
Updated: 1/4/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Seizure Detection and Warning System in Epilepsy Patients
A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
Status: Enrolling
Updated:  1/4/2017
Jose' E. Cavazos
mi
from
San Antonio, TX
Seizure Detection and Warning System in Epilepsy Patients
A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
Status: Enrolling
Updated: 1/4/2017
Jose' E. Cavazos
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
Status: Enrolling
Updated:  1/4/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
Status: Enrolling
Updated: 1/4/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS)
Non-Invasive Measurement of GI Motility in Patients With ALS
Status: Enrolling
Updated:  1/5/2017
MDA/ALS Center of Hope
mi
from
Philadelphia, PA
Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS)
Non-Invasive Measurement of GI Motility in Patients With ALS
Status: Enrolling
Updated: 1/5/2017
MDA/ALS Center of Hope
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program
ALS Tissue Donation Program
Status: Enrolling
Updated:  1/5/2017
MDA/ALS Center of Hope
mi
from
Philadelphia, PA
Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program
ALS Tissue Donation Program
Status: Enrolling
Updated: 1/5/2017
MDA/ALS Center of Hope
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
Evaluation of [18F]PEB and Positron Emission Tomography (PET) as a Marker of mGluR5 in Subjects w/ Neuropsychiatric Conditions
Status: Enrolling
Updated:  1/5/2017
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
Evaluation of [18F]PEB and Positron Emission Tomography (PET) as a Marker of mGluR5 in Subjects w/ Neuropsychiatric Conditions
Status: Enrolling
Updated: 1/5/2017
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.
Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in Subjects With Parkinson Disease, Huntington Disease, and Healthy Controls
Status: Enrolling
Updated:  1/5/2017
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.
Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in Subjects With Parkinson Disease, Huntington Disease, and Healthy Controls
Status: Enrolling
Updated: 1/5/2017
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
miRNA Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
Status: Enrolling
Updated:  1/5/2017
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
miRNA Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
Status: Enrolling
Updated: 1/5/2017
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Identification of Novel Molecular Markers for Vasospasm
Identification of Novel Molecular Markers for Vasospasm From the Cerebrospinal Fluid (CSF) of Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/5/2017
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Identification of Novel Molecular Markers for Vasospasm
Identification of Novel Molecular Markers for Vasospasm From the Cerebrospinal Fluid (CSF) of Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/5/2017
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke Survivors With Multiple Lesions
Status: Enrolling
Updated:  1/5/2017
Kessler Insitute for Rehabilitaiton
mi
from
Saddle Brook, NJ
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke Survivors With Multiple Lesions
Status: Enrolling
Updated: 1/5/2017
Kessler Insitute for Rehabilitaiton
mi
from
Saddle Brook, NJ
Click here to add this to my saved trials
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke Survivors With Multiple Lesions
Status: Enrolling
Updated:  1/5/2017
Kessler Institute for Rehabiltiation
mi
from
West Orange, NJ
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke Survivors With Multiple Lesions
Status: Enrolling
Updated: 1/5/2017
Kessler Institute for Rehabiltiation
mi
from
West Orange, NJ
Click here to add this to my saved trials
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/9/2017
HOPE Research Institute
mi
from
Phoenix, AZ
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/9/2017
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/9/2017
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/9/2017
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/9/2017
Alta Bates Summit Medical Center, The Research and Education Development Institute
mi
from
Berkeley, CA
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/9/2017
Alta Bates Summit Medical Center, The Research and Education Development Institute
mi
from
Berkeley, CA
Click here to add this to my saved trials
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/9/2017
Neurology Associates, PA
mi
from
Maitland, FL
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/9/2017
Neurology Associates, PA
mi
from
Maitland, FL
Click here to add this to my saved trials
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/9/2017
University of Miami
mi
from
Miami, FL
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/9/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/9/2017
Collier Neurologic Specialists
mi
from
Naples, FL
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/9/2017
Collier Neurologic Specialists
mi
from
Naples, FL
Click here to add this to my saved trials